Journal of Bioavailability and Bioequivalence Studies is an open access, peer reviewed journal is dedicated to publish comprehensive research insights in understanding pharmacokinetics used to assess the expected in vivo biological equivalence of two proprietary preparations of a drug absorption and is the fraction of an administered dose of unchanged drug that reaches the systemic circulation, one of the principal pharmacokinetic properties of drugs. It majorly includes the disciplines such as bioaccessibility, bioequivalence and bioavailability.
The journal is pleased to invite, contribute, share and promote the word of open access. All its published content could be use and reuse with no restriction barriers when properly cited of the scholarly work under the terms of Creative Commons Attribution License. It invites various article forms such as original, reviews, commentaries, rapid communications, letters, opinions, perspectives and other short articles.
This is an important journal that provides an excellent forum for studies that play an important role during the process of drug development and it applies to both new drugs as well as to their generic equivalents.
Founder and Chairman
Pharmaceutical Product Development
IriSys LLC, San Diego, California
United states of America
Tel: 858-228-6983
Professor
Department of Microbiology and Immunology
Stanford University School of Medicine
United States of America
Tel: 650-725-4745
Director
Department of Imaging
Rovigo General Hospital
Italy
Tel: +39 0425 39 4428
Professor
Department of Agricultural Chemistry, Geology and Edaphology
University of Murcia
Spain
Tel: 34-868887473
Senior Scientist
Department of Drug discovery
Freiburg
Germany
Tel: +49-0-30-40-39-47-18
Senior Director
Pharmaceutical Development
Zosano Pharma, Fremont
United States of America
Tel: 510-754-8592
Submit your manuscript to this journal through online or email us at editorialoffice@scholars.direct
